Antibody Isotype:
Rabbit Ig
Antibody Clonality:
Polyclonal
Application:
Western Blot (WB)
Storage:
Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
No additional charges, what you see is what you pay! *
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available!
Contact us to find what you can save.
This product comes from:
United States.
Typical lead time:
14-21 working days.
Contact us for more accurate information.
- Further Information
- Documents
- Show All
Further Information
N-alpha-acetyltransferase 15, NatA auxiliary subunit, Gastric cancer antigen Ga19, N-terminal acetyltransferase, NMDA receptor-regulated protein 1, Protein tubedown-1, Tbdn100, NAA15, GA19, NARG1, NATH, TBDN100
For WB starting dilution is: 1:1000
This gene encodes a protein of unknown function. However,
similarity to proteins in yeast and other species suggests that
this protein may be an N-acetyltransferase.
- Arnesen, T., et al. Mol. Cell. Biol. 30(8):1898-1909(2010)
- Polevoda, B., et al. BMC ProcSUPPL 6, S2 (2009) :
- Olsen, J.V., et al. Cell 127(3):635-648(2006)
- Olsen, J.V., et al. Cell 127(3):635-648(2006)
Supplied in PBS with 0.09% (W/V) sodium azide.
batch dependent
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Predicted species reactivity based on immunogen sequence: Mouse
This NARG1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 157-185 amino acids from the N-terminal region of human NARG1.
80155
N-alpha-acetyltransferase 15, NatA auxiliary subunit
NAA15
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
101 kDa
Q9BXJ9
57012969
This antibody is purified through a protein A column, followed by peptide affinity purification.
Q9BXJ9
Optimal dilutions for each application to be determined by the researcher.